Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
10/2005
10/11/2005US6953813 2-Aminotetralin derivatives for the therapy of glaucoma
10/11/2005US6953810 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
10/11/2005US6953804 alkenyl ether functionality at 1-position; immunomodulators that induce cytokine biosynthesis; 1-[2-(2-Propynyloxy)ethyl]-1H-imidazo[4,5-c]quinolin-4-amine;
10/11/2005US6953797 Nitric oxide synthase inhibitor; antiinflammatory agents
10/11/2005US6953796 Use of 2-amino-thiazoline derivatives as inhibitors of inducible No-synthase
10/11/2005US6953776 Ophthalmic formulations
10/11/2005CA2315818C Water-soluble eye drop
10/06/2005WO2005092889A1 Composition for solid pharmaceutical preparation of solifenacin or salt thereof
10/06/2005WO2005092348A1 Hgf production accelerator containing heparin-like oligosaccharide
10/06/2005WO2005072066A3 Preventive or therapeutic agent for diabetic maculopathy
10/06/2005WO2004098499A3 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
10/06/2005US20050222423 Carboxylic acid derivative
10/06/2005US20050222414 N-(4-methylphenyl)-4-[4-[[(phenylmethoxy)amino]carbonyl]phenyl]-1-piperazinecarboxamide; anticarcinogenic, antiproliferative agent; ovarian carcinoma, psoriasis; gene transcription control
10/06/2005US20050222410 Inhibitors of histone deacetylase
10/06/2005US20050222387 Smac-peptides as therapeutics against cancer and autoimmune diseases
10/06/2005US20050222384 Useful as prophylactic and therapeutic agent of dysfunction of masticatory, dysphagia, dysgeusia, ozostomia, intra-oral cavity dysphoria, intra-oral cavity infections, intra-oral cavity inflammations, dry eye, ectocornea detachment, keratitis, corneal ulcer, conjunctivitis, stomach and duodenal ulcers
10/06/2005US20050222244 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors
10/06/2005US20050222243 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
10/06/2005US20050222201 such as 3-(2-chloro-4-quinolinyl)-2,5-dimethyl-1H-indole-1-acetic acid, used for treating respiratory system disorders and as inhibitors of G protein-coupled receptor chemoattractant homologous receptor expressed on lymphocyte cells (CRTH2)
10/06/2005US20050222196 Azabicyclic-substituted fused heteroaryl compounds for the treatment of disease
10/06/2005US20050222194 3-[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-quinolin-2(1H)-ones or 5--[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-pyrrolo[3,2,1-IJ]quinolin-4(4H)-ones; type E antagonists; analgesics, antipyretics, antiinflammatory agents; side effect reduction
10/06/2005US20050222189 Oxa-and thiadiazoles and their use as metalloproteinase inhibitors
10/06/2005US20050222172 Active ingredient in treating neurodegenerative disease, Alzheimer's disease caused by abnormal enzyme activity
10/06/2005US20050222160 1-[3-(3-cyclopentyloxy-4-methoxyphenyl)-3,4,5,6-tetrahydropyridazin-1-yl]-1-[4-methyl-2-(1-oxypyridin-2-yl)thiazol-5-yl]methanone, used for inhibiting proliferation of lymphocytes in a host, and for the treatment of osteoporosis, tumors, cachexia, atherosclerosis, arthritis, multiple sclerosis, diabetes
10/06/2005US20050222147 Process for the preparation of morpholine derivatives and intermediates therefore
10/06/2005US20050222137 Combination of organic compounds
10/06/2005US20050222085 Quaternised ammonium cyclodextrin compounds
10/06/2005US20050222084 Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect
10/06/2005US20050222083 Thiol-modified hyaluronan
10/06/2005US20050222065 Vascular therapeutics
10/06/2005US20050222061 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye
10/06/2005US20050222025 Method of inhibiting fibrosis with a somatostatin agonist
10/06/2005US20050221420 Nogo receptor homologues and their use
10/06/2005US20050221330 Glial cell line-derived neurotrophic factor (GDNF); nervous system disorders, autonomic nervous system, shingles, asthma, irritable bowel, inflammatory bowel, constipation, headache, arthritis, spinal cord injury, chronic back pain, hypertension, mucositis, diabetes, fibromyalgia, and wound healing
10/06/2005US20050221317 Use of an epitope of vascular endothelial growth factor receptor kdr/flk-1
10/06/2005US20050220823 Ophthalmic composition comprising ascomycin
10/06/2005US20050220802 Vaccine and method for treatment of motor neurone diseases
10/06/2005CA2560988A1 Use of a phenothiazine derivative for preventing and/or treating hearing loss
10/06/2005CA2534445A1 Agent for promoting hgf production comprising heparin-like oligosaccharides
10/05/2005EP1582212A1 Intravitreally-injectable solution for the treatment of vitreous haemorrhages
10/05/2005EP1581212A2 Superoxide dismutase mimics for the treatment of ocular disorders and diseases
10/05/2005EP1581211A1 Contact lens and eye drop rewetter compositions and their uses
10/05/2005EP1581047A2 Radiopaque animal chew
10/05/2005EP1233950B1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/P39 kINASE INHIBITORS
10/05/2005EP1183233B1 Bradykinin receptor antagonists
10/05/2005CN1678607A Nitrogen-containing aromatic ring derivatives
10/05/2005CN1678594A Morpholin-acetamide derivatives for the treatment of inflammatory diseases
10/05/2005CN1678586A 取代的喹啉ccr5受体拮抗剂 Substituted quinoline ccr5 receptor antagonist
10/05/2005CN1678585A Therapeutic agents useful for treating pain
10/05/2005CN1678573A Diarylurea derivatives and their use as chloride channel blockers
10/05/2005CN1678572A Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid
10/05/2005CN1678347A Antibodies and uses thereof
10/05/2005CN1678342A Treatment for eye disorder
10/05/2005CN1678333A Composition comprising the extract of actinidia arguta and related species for the prevention and treatment of allergic disease and non-allergic inflammatory disease
10/05/2005CN1678325A Sapogenin derivatives, their synthesis and use and method based upon the use
10/05/2005CN1678320A N-biarylmethyl aminocycloalkanecarboxamide derivatives
10/05/2005CN1678317A 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related compounds as neurokinin-1(NK-1) antagonists for the treatment of emesis, depression, anxiety and cough
10/05/2005CN1676134A Artificial tear and its preparing method
10/05/2005CN1221570C Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant
10/05/2005CN1221548C Oxazolidinones having sulfoximine functional group
10/05/2005CN1221279C Use of ginkgo leaf extract for preparing preparation with protection effect to optic nerve retina ganglion cell
10/05/2005CN1221270C Method for preparation of eye drop of bark of ash
10/05/2005CN1221262C Phthalazine derivatives for treating inflammatory diseases
10/05/2005CN1221254C New combination of serotonin agonist (5HT2) and antagonist (5HT6) as pharmaceutical formulation
10/04/2005US6951890 Preventing and/or treating cardiovascular disease and/or associated heart failure
10/04/2005US6951889 7-acetamidinyl derivatives
10/04/2005US6951876 Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents
10/04/2005US6951874 Compounds
10/04/2005US6951871 Indole derivatives useful as histamine H3 antagonists
10/04/2005US6951868 Central nervous system disorders, gastrointestinal disorders;side effect reduction
10/04/2005US6951857 Interleukins; cytokines; for treating eosinophil-dependent inflammatory disease/bronchial asthma
10/04/2005US6951641 administering a dimeric nonionic X-ray contrast media selected from iotrolan and iodixannol to an eye of a mammal suffering allergic conjunctivtis and allergic rhinitis
09/2005
09/29/2005WO2005090340A1 Piperidine-1-carboxamide derivative
09/29/2005WO2005090332A1 Substituted quinazoline or pyridopyrimidine derivative
09/29/2005WO2005089802A1 Therapeutic agent for auris interna disorder containing il-6 antagonist as active ingredient
09/29/2005WO2005089714A1 Emulsion stabilizer
09/29/2005US20050215607 Drug composition for prevention or inhibition of advance of diabetic complication
09/29/2005US20050215593 Kaposi's sarcoma; Crohn's disease
09/29/2005US20050215584 Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatment of disease
09/29/2005US20050215557 For therapy and prophylaxis of inflammatory diseases, asthma, atopic dermatitis, urticaria, allergic diseases, nephritis, nephropathy, hepatitis, arthritis or rheumatoid arthritis etc
09/29/2005US20050215550 Pyrazole-derived kinase inhibitors and uses thereof
09/29/2005US20050215549 TACE inhibitors
09/29/2005US20050215547 Optically active pyridine derivative and a medicament containing the same
09/29/2005US20050215502 Regulation of endogenous gene expression in cells using zinc finger proteins
09/29/2005US20050215497 Treating prostate cancer by administering double stranded oligonucleotide having two complementary oligonucleotide sequences forming a hybrid; each sequence has at one 3' or 5' end 1-5 unpaired nucleotides forming single-strand ends extending beyond the hybrid
09/29/2005US20050215496 Preparation and diabetic use of Gibberellins
09/29/2005US20050214384 Chromium compositions and methods for using the same for inhibiting drug-induced insulin resistance
09/29/2005US20050214334 Composition for topical substance delivery
09/29/2005US20050214291 Treatment method
09/29/2005CA2562388A1 Emulsion-stabilized preparation
09/29/2005CA2560953A1 Therapeutic agent for auris interna disorder containing il-6 antagonist as active ingredient
09/29/2005CA2560286A1 Substituted quinazoline or pyridopyrimidine derivative
09/29/2005CA2559545A1 Tetra-cyclic carboline derivatives for inhibiting angiogenesis
09/29/2005CA2559436A1 Materials for treating vascular leakage in the eye
09/29/2005CA2559161A1 Irna agents targeting vegf
09/28/2005EP1579871A1 Vascular endothelial cell growth factor antagonists and uses thereof
09/28/2005EP1579868A2 Use of IL-11 for treating various diseases
09/28/2005EP1578917A2 Multimeric proteins and methods of making and using same
09/28/2005EP1578915A2 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and for enhancing survival of neurons and uses thereof
09/28/2005EP1448521B1 Derivatives of andrimide and moiramide b having antibacterial properties
1 ... 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 ... 531